Global Benign Prostatic Hyperplasia and Prostatitis Device-based Treatments Market 2016-2021

This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for BPH and prostatitis treatment devices.

Topics Covered Include:

Report Highlights:

Key Topics Covered:

Executive Summary
i. Methodology

1. Clinical Overview of Benign Prostatic Hyperplasia and Prostatitis
1.1 Benign Prostatic Hyperplasia
1.1.1 Symptoms
1.1.2 Diagnosis
1.1.3 Prevalence
1.1.4 Treatment
1.2 Prostatitis
1.2.1 Symptoms
1.2.2 Diagnosis
1.2.3 Treatments
1.3 Bibliography

2. Products for Treating Symptomatic Benign Prostatic Hyperplasia
2.1 Established Therapeutic Approaches
2.1.1 Drug therapy
2.1.2 Surgical treatment
2.1.2.1 Transurethral resection of the prostate
2.1.2.1.1 Selected TURP/BPVP products
2.1.2.1.1.1 KARL STORZ
2.1.2.1.1.2 Olympus
2.1.2.1.1.3 Richard Wolf
2.1.3 Less invasive alternatives to surgery
2.1.3.1 Transurethral incision of the prostate (TUIP)
2.1.3.2 Laser-based techniques
2.1.3.3 Other energy-based procedures
2.1.3.4 Prostatic implants
2.1.3.5 Prostatic artery embolization
2.1.3.6 Clinical development
2.2 Market Forecasts
2.2.1 Global market for TURP equipment and related.products for BPH
2.2.2 Global market for laser-based products for BPH
2.2.3 Global market for microwave and RF thermotherapy products for BPH
2.2.4 Global market for prostatic urethral lift implants for BPH
2.2.5 Global market for prostatic stents and PAE products for BPH
2.2.6 Market forecast: US
2.2.7 Market forecast: EU
2.2.8 Market forecast: Japan
2.2.9 Market forecast: rest of the world
2.3 Competitive Analysis
2.3.1 TURP and related equipment for vaporization and enucleation
2.3.2 Laser systems
2.3.2.1 TUMT/TUNA
2.4 Bibliography

3. Products for Treating Symptomatic Prostatitis
3.1 Established Therapeutic Approaches
3.1.1 Drug therapy
3.1.1.1 Clinical development
3.1.2 Conservative non-pharmacologic therapy
3.1.3 Surgical/minimally invasive treatments
3.1.3.1 TURP
3.1.3.2 Minimally invasive thermotherapy
3.1.3.2.1 Microwave thermotherapy
3.1.3.3 External shock wave therapy
3.2 Market Forecasts
3.3 Bibliography

Appendix: Company Listing

For more information about this report visit https://www.researchandmarkets.com/research/qgrwf6/benign_prostatic

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716